We are live on
!
Find out more
Federated Hermes Portfolio holdings
AUM
$69.6B
1-Year Est. Return
42.52%
This Fund
S&P 500
This Quarter
Est. Return
+5%
1 Year Est. Return
+42.52%
3 Year Est. Return
+132.48%
5 Year Est. Return
+152.58%
10 Year Est. Return
+652.43%
AUM
$40.3B
AUM Growth
+$535M
(+1.3%)
Cap. Flow
-$468M
Cap. Flow
% of AUM
-1.16%
Top 10 Holdings %
Top 10 Hldgs %
15.78%
Holding
2,279
New
170
Increased
711
Reduced
1,071
Closed
189
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amgen
AMGN
|
+$178M |
| 2 |
LyondellBasell Industries
LYB
|
+$133M |
| 3 |
AT&T
T
|
+$124M |
| 4 |
Stanley Black & Decker
SWK
|
+$101M |
| 5 |
Pfizer
PFE
|
+$93.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Clorox
CLX
|
+$229M |
| 2 |
Gilead Sciences
GILD
|
+$164M |
| 3 |
Broadcom
AVGO
|
+$149M |
| 4 |
KeyCorp
KEY
|
+$145M |
| 5 |
Darden Restaurants
DRI
|
+$125M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 20.22% |
| 2 | Technology | 14.47% |
| 3 | Financials | 10.84% |
| 4 | Industrials | 9.01% |
| 5 | Consumer Discretionary | 8.84% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ESMT
1801
DELISTED
EngageSmart, Inc.
ESMT
| $14.9K | ﹤0.01% |
779
-682
| -47% | -$12.1K |
|
1802
Laureate Education
LAUR
$4.94B
| $14.7K | ﹤0.01% |
1,215
-238
| -16% | -$2.85K |
|
1803
MGP Ingredients
MGPI
$308M
| $14.5K | ﹤0.01% |
136
-87
| -39% | -$8.7K |
|
1804
Coupang
CPNG
$26.4B
| $14.4K | ﹤0.01% |
828
| – | – |
|
1805
Outdoor Holding Co
POWW
$248M
| $14.3K | ﹤0.01% |
6,722
| – | – |
|
1806
United Fire Group
UFCS
$1.41B
| $14.2K | ﹤0.01% |
628
-550
| -47% | -$13.6K |
|
1807
Ocular Therapeutix
OCUL
$2.24B
| $14.2K | ﹤0.01% |
2,747
+2,527
| +1,149% | +$15K |
|
1808
Western Alliance Bancorporation
WAL
$8.62B
| $14.1K | ﹤0.01% |
387
-143,234
| -100% | -$4.97M |
|
|
VSTO
1809
DELISTED
Vista Outdoor Inc.
VSTO
| $13.6K | ﹤0.01% |
490
-2,099
| -81% | -$56.8K |
|
1810
Tidewater
TDW
$4.57B
| $13.4K | ﹤0.01% |
241
-8
| -3% | -$366 |
|
1811
Varex Imaging
VREX
$778M
| $13.3K | ﹤0.01% |
563
+99
| +21% | +$2.06K |
|
1812
Costamare
CMRE
$1.83B
| $12.9K | ﹤0.01% |
1,338
-1,171
| -47% | -$10.5K |
|
1813
Napco Security Technologies
NSSC
$1.29B
| $12.9K | ﹤0.01% |
373
+271
| +266% | +$9.46K |
|
1814
Vita Coco
COCO
$3.23B
| $12.9K | ﹤0.01% |
479
+241
| +101% | +$5.87K |
|
1815
iShares MSCI Japan ETF
EWJ
$23.3B
| $12.8K | ﹤0.01% |
206
| – | – |
|
1816
Upland Software
UPLD
$11.1M
| $12.7K | ﹤0.01% |
353
-38,788
| -99% | -$1.34M |
|
1817
FS Bancorp
FSBW
$350M
| $12.6K | ﹤0.01% |
419
| – | – |
|
1818
Cass Information Systems
CASS
$711M
| $12.5K | ﹤0.01% |
322
-281
| -47% | -$11K |
|
1819
S&T Bancorp
STBA
$1.78B
| $12.5K | ﹤0.01% |
459
| – | – |
|
1820
Core & Main
CNM
$7.58B
| $12.4K | ﹤0.01% |
+395
| New | +$10.6K |
|
1821
Olema Pharmaceuticals
OLMA
$856M
| $12K | ﹤0.01% |
1,332
-377
| -22% | -$2.28K |
|
1822
Root
ROOT
$830M
| $11.9K | ﹤0.01% |
1,326
-413
| -24% | -$2.28K |
|
1823
Oscar Health
OSCR
$10B
| $11.8K | ﹤0.01% |
+1,463
| New | +$10.8K |
|
1824
Merchants Bancorp
MBIN
$2.43B
| $11.7K | ﹤0.01% |
457
-35
| -7% | -$866 |
|
|
FSP
1825
Franklin Street Properties
FSP
$34.9M
| $11.3K | ﹤0.01% |
7,809
+2,667
| +52% | +$3.69K |
|
Similar funds
Federated Hermes's Q2 2023 Portfolio in Review
As of Q2 2023, Federated Hermes held 2,279 positions worth $40.3B, up 1.3% from $39.7B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Federated Hermes's Q2 2023 filing shows 170 new, 711 increased, 1,071 reduced and 189 closed positions. Its largest new stake was HashiCorp, Inc. Class A Common Stock: 1,317,400 shares worth $34.5M. The largest sale was Clorox, an estimated $229M.
By sector, the portfolio is most concentrated in Healthcare at 20% of assets, up from 20% a quarter earlier, followed by Technology and Financials.
- Federated Hermes's largest Q2 2023 buy was HashiCorp, Inc. Class A Common Stock: 1,317,400 shares worth $34.5M.
- Federated Hermes added most to Amgen in Q2 2023, an estimated $178M increase.
- Federated Hermes's biggest Q2 2023 reduction was Clorox, cutting an estimated $229M.
- Federated Hermes fully exited Prometheus Biosciences, Inc. Common Stock in Q2 2023, selling an estimated $55.4M.
- Federated Hermes's ten largest holdings make up 16% of its $40.3B portfolio in Q2 2023.
- Federated Hermes opened 170 new positions and closed 189 in Q2 2023.
- Federated Hermes's portfolio value rose 1.3% quarter-over-quarter to $40.3B.
Based on Federated Hermes's 13F filing for Q2 2023, filed 14 Aug 2023.